Top Page
Hiscox
(LSE:HSX)
Hiscox (HSX) vs. iShares MSCI United Kingdom ETF (EWC)
Hiscox Business Overview & Revenue Model
Hiscox Earnings Call Summary
Hiscox Financial Statement Overview
| Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 3.81B | 3.70B | 2.98B | 3.29B | 3.25B |
| Gross Profit | 3.68B | 3.58B | 2.98B | 3.29B | 3.25B |
| EBITDA | 799.20M | 730.00M | 335.60M | 248.20M | -199.70M |
| Net Income | 627.20M | 712.00M | 253.90M | 189.50M | -293.70M |
Balance Sheet | |||||
| Total Assets | 11.24B | 11.06B | 13.72B | 13.85B | 13.86B |
| Cash, Cash Equivalents and Short-Term Investments | 1.23B | 1.47B | 1.40B | 1.35B | 1.64B |
| Total Debt | 743.00M | 754.20M | 635.90M | 746.50M | 946.10M |
| Total Liabilities | 7.55B | 7.76B | 11.31B | 11.31B | 11.50B |
| Stockholders Equity | 3.69B | 3.30B | 2.42B | 2.54B | 2.35B |
Cash Flow | |||||
| Free Cash Flow | 75.30M | 188.40M | 290.60M | -42.30M | -188.60M |
| Operating Cash Flow | 114.40M | 232.10M | 373.40M | 16.60M | -117.10M |
| Investing Cash Flow | -38.50M | -34.20M | -81.90M | -36.60M | -52.70M |
| Financing Cash Flow | -282.60M | -128.90M | -190.90M | -246.20M | 592.80M |
Hiscox Technical Analysis
Hiscox Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | £10.19B | 15.36 | 56.17% | 8.54% | 34.86% | 95.18% | |
77 Outperform | £1.53B | 5.97 | 21.23% | 5.76% | 14.46% | -2.98% | |
76 Outperform | £5.59B | 6.68 | 26.32% | 2.73% | 7.79% | 9.99% | |
71 Outperform | $4.33B | 8.97 | 17.96% | 2.42% | 3.60% | -13.17% | |
65 Neutral | £370.27M | 10.36 | 14.37% | 4.53% | 32.88% | 99.17% | |
64 Neutral | $6.61B | 11.16 | 7.19% | 5.24% | 24.10% | 5.12% |
Hiscox Corporate Events
Hiscox Ltd has executed a share buyback program, purchasing 40,000 ordinary shares at a consistent price of 1,259 GBp each. This transaction, conducted through Peel Hunt LLP, is part of a broader strategy announced earlier in the year, aimed at optimizing the company’s capital structure and potentially enhancing shareholder value.
The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd announced the purchase of 40,000 of its own ordinary shares as part of its ongoing share buyback programme. The shares were bought at a volume-weighted average price of 1,255.75 GBp and will be cancelled, which is expected to positively impact the company’s stock value and shareholder returns.
The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has announced the purchase of 10,000 of its own ordinary shares as part of its ongoing share buyback program. The shares were acquired at a consistent price of 1,245 GBp per share and will be cancelled, reflecting the company’s strategic efforts to manage its capital structure and potentially enhance shareholder value.
The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has announced the purchase of 40,000 of its own ordinary shares as part of its share buyback program, with prices ranging from 1,228.00 GBp to 1,240.00 GBp. This move is part of the company’s strategy to manage its capital structure and potentially enhance shareholder value by reducing the number of outstanding shares.
The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has executed a share buyback program, purchasing 40,000 of its own ordinary shares at a volume-weighted average price of 1,240.50 GBp per share. This move is part of a previously announced buyback initiative and reflects the company’s strategy to manage its capital structure, potentially enhancing shareholder value by reducing the number of shares outstanding.
The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has executed a share buyback transaction as part of its previously announced Buyback Programme, purchasing 40,000 Ordinary Shares at a price of 1,242.00 GBp per share. This move is part of the company’s strategy to manage its capital structure and potentially enhance shareholder value by reducing the number of shares in circulation.
The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has executed a share buyback program, purchasing 40,000 of its own ordinary shares through Peel Hunt LLP, with prices ranging from 1,256.00 GBp to 1,261.00 GBp. This move, part of a previously announced buyback program, is aimed at enhancing shareholder value by reducing the number of shares in circulation, potentially increasing the value of remaining shares.
The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has announced the purchase of 50,000 of its own ordinary shares as part of its ongoing share buyback programme, with the shares bought at a volume weighted average price of 1,248.00 GBp. This move is part of Hiscox’s strategy to enhance shareholder value and optimize its capital structure, reflecting confidence in its financial stability and future growth prospects.
The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has executed a share buyback transaction as part of its ongoing Buyback Programme, purchasing 40,000 Ordinary Shares at a consistent price of 1,238.00 GBp per share. This strategic move, conducted through Peel Hunt LLP, reflects Hiscox’s commitment to optimizing its capital structure and potentially enhancing shareholder value by reducing the number of shares in circulation.
The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has executed a share buyback, purchasing 50,000 of its own ordinary shares as part of its ongoing Buyback Programme. The shares were acquired at a volume-weighted average price of 1,259.28 GBp and will be canceled, reflecting the company’s strategy to manage its capital structure and potentially enhance shareholder value.
The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has executed a share buyback transaction, purchasing 30,000 of its own ordinary shares as part of its previously announced buyback programme. The shares were acquired at a volume-weighted average price of 1,257.33 GBp and will be subsequently cancelled, indicating a strategic move to optimize capital structure and potentially enhance shareholder value.
The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has announced its total voting rights as of June 30, 2025, with an issued ordinary share capital of 344,459,352 shares, of which 7,523,190 are held in treasury and do not carry voting rights. This results in a total of 336,936,162 voting rights, which shareholders can use to calculate their interests in the company under the Disclosure and Transparency Rules.
The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has executed a share buyback program, purchasing 30,000 of its own ordinary shares at an average price of 1,262.83 GBp per share. This move is part of the company’s strategy to manage its capital structure and potentially enhance shareholder value by reducing the number of shares in circulation.
The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has executed a share buyback, purchasing 25,000 ordinary shares at a volume-weighted average price of 1,268 GBp per share. This transaction is part of a previously announced buyback programme, and the acquired shares will be cancelled, potentially enhancing shareholder value by reducing the number of shares outstanding.
The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has executed a share buyback program, purchasing 30,000 of its own ordinary shares at prices ranging from 1,263.00 GBp to 1,266.00 GBp, with a volume-weighted average price of 1,265.00 GBp. The shares acquired through this program will be cancelled, which is expected to impact the company’s share capital structure positively by potentially increasing the value of remaining shares and demonstrating confidence in the company’s financial health.
The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd, a non-UK issuer, has announced a change in its major holdings as Boston Partners, previously known as Robeco Investment Management, Inc., has increased its voting rights in the company to 5.18% from a previous 4.93%. This change, effective as of June 25, 2025, indicates a strategic move by Boston Partners, potentially impacting Hiscox’s shareholder dynamics and signaling confidence in the company’s future prospects.
The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has executed a share buyback transaction, purchasing 30,000 of its own ordinary shares at a price of 1,269 GBp per share. This move is part of the company’s ongoing share buyback programme announced earlier in the year, aimed at enhancing shareholder value by reducing the number of shares in circulation. The purchased shares will be canceled, potentially impacting the company’s stock value and market perception positively.
The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has announced the purchase of 30,000 of its own ordinary shares as part of its share buyback program initiated earlier in the year. The shares were bought at a volume-weighted average price of 1,273 GBp and will be canceled, which is expected to impact the company’s share capital structure and potentially enhance shareholder value.
The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has announced the purchase of 30,000 of its own ordinary shares as part of its ongoing share buyback programme. The shares were bought at a volume-weighted average price of 1,262.08 GBp and will be cancelled, reflecting the company’s commitment to returning value to shareholders and potentially improving its stock value.
The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has executed a share buyback programme, purchasing 30,000 of its own ordinary shares at a price of 1,287 pence per share. This move is part of a strategic initiative to manage the company’s capital structure and potentially enhance shareholder value by reducing the number of shares in circulation.
The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has executed a share buyback transaction, purchasing 30,000 ordinary shares at a volume weighted average price of 1,269.67 GBp per share. This move is part of its ongoing share buyback programme announced earlier in the year, and the purchased shares will be cancelled, potentially impacting the company’s share value and shareholder equity.
The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd announced the purchase of 30,000 of its own ordinary shares as part of its ongoing share buyback programme. The shares were bought at a volume-weighted average price of 1,283.75 GBp and will be cancelled, reflecting the company’s commitment to returning value to shareholders and optimizing its capital structure.
The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has executed a share buyback program, purchasing 30,000 of its own ordinary shares at prices ranging from 1,290.00 GBp to 1,292.00 GBp. This move is part of a previously announced buyback initiative and is expected to impact the company’s share value positively by reducing the number of shares in circulation, potentially increasing earnings per share and shareholder value.
The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has successfully completed a tender offer for its Fixed to Floating Rate Callable Subordinated Notes due 2045, accepting £261,208,000 in aggregate principal amount of the Notes. This move follows the issuance of new notes and satisfies the New Financing Condition, with the remaining Notes being cancelled, leaving £13,792,000 outstanding. The tender offer and new financing are part of Hiscox’s strategic financial management, potentially impacting its market positioning and stakeholder interests.
The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has executed a share buyback program, purchasing 30,000 of its own ordinary shares at a price of 1,325 pence per share. This move is part of a previously announced buyback initiative, and the purchased shares will be cancelled, potentially impacting the company’s share value and market positioning.
The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has executed a share buyback program, purchasing 30,000 of its own ordinary shares at an average price of 1,318.33 GBp per share. This move is part of a previously announced strategy to enhance shareholder value, and the purchased shares will be cancelled, potentially impacting the company’s stock value and market perception.
The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has announced the purchase of 20,000 of its own ordinary shares as part of its ongoing share buyback programme. The shares were bought at prices ranging from 1,346.00 GBp to 1,351.50 GBp and will be cancelled, which is expected to enhance shareholder value and optimize the company’s capital structure.
The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has executed a share buyback program, purchasing 30,000 ordinary shares at a volume-weighted average price of 1,333.25 GBp per share. This move is part of a broader strategy to manage its capital structure and potentially enhance shareholder value by reducing the number of shares in circulation.
The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has announced its application to have 146,706 Ordinary Shares admitted to the Official List of the Financial Conduct Authority and the London Stock Exchange. These shares are part of the company’s Scrip Dividend Alternative related to the final dividend and are expected to be listed on June 9, 2025. This move is likely to enhance the company’s financial flexibility and provide shareholders with additional options for dividend reinvestment, potentially strengthening Hiscox’s market position.
The most recent analyst rating on (GB:HSX) stock is a Hold with a £14.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has announced a change in the voting rights held by Boston Partners, formerly known as Robeco Investment Management, Inc., which is based in New York, USA. As of June 2, 2025, Boston Partners’ voting rights in Hiscox have decreased from 5.298% to 4.93%, marking a disposal of voting rights. This change may impact Hiscox’s shareholder dynamics and influence within the company, although the broader implications for stakeholders are not detailed in the release.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £1500.00 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has executed a share buyback program, purchasing 40,000 ordinary shares at a volume-weighted average price of 1,302.50 GBp per share. This move is part of a previously announced buyback initiative, reflecting the company’s strategy to manage its capital structure and potentially enhance shareholder value.
The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has announced the U.S. dollar Maximum Acceptance Amount for its tender offer concerning its Fixed to Floating Rate Callable Subordinated Notes due 2045. The company has set the Maximum Acceptance Amount at $500 million, which will be converted into sterling based on the prevailing exchange rate at the expiration deadline. This move is part of Hiscox’s strategic financial management, potentially impacting its financial structure and market positioning.
The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has executed a share buyback program, purchasing 40,000 ordinary shares at an average price of 1,283.18 GBp per share. This move is part of a previously announced buyback initiative, and the purchased shares will be cancelled, potentially enhancing shareholder value and reflecting confidence in the company’s financial health.
The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has executed a share buyback program, purchasing 45,000 of its own ordinary shares at prices ranging from 1,268.00 GBp to 1,284.00 GBp, with a volume-weighted average price of 1,275.11 GBp. This move is part of a previously announced buyback programme aimed at enhancing shareholder value by reducing the number of outstanding shares, which can positively impact earnings per share and market perception.
The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has announced its total voting rights as of May 30, 2025, with an issued ordinary share capital of 344,616,100 shares, of which 7,523,190 are held in Treasury and do not carry voting rights. This results in a total of 337,092,910 voting rights, which shareholders can use to calculate their interests in accordance with the Disclosure and Transparency Rules.
The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has announced a tender offer for its £275,000,000 Fixed to Floating Rate Callable Subordinated Notes due 2045, inviting holders to tender their notes for purchase. This move is part of Hiscox’s strategy to refinance existing debt and manage its debt maturity profile proactively. The offer includes the issuance of new U.S. dollar-denominated fixed to floating rate callable subordinated notes, contingent upon market conditions. This financial maneuver is expected to impact Hiscox’s operations by optimizing its debt structure, potentially affecting stakeholders who hold or intend to purchase these financial instruments.
The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has executed a share buyback transaction as part of its previously announced Buyback Programme, purchasing 25,000 Ordinary Shares at a volume weighted average price of 1,274.40 GBp. This move is part of the company’s strategy to manage its capital structure and enhance shareholder value by reducing the number of shares in circulation.
The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has executed a share buyback program, purchasing 25,000 of its own ordinary shares through Peel Hunt LLP. The shares were bought at prices ranging from 1,272.00 GBp to 1,281.00 GBp and will be cancelled, reflecting the company’s strategic move to manage its capital structure and potentially enhance shareholder value.
The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has executed a share buyback, purchasing 25,000 of its own ordinary shares as part of its previously announced Buyback Programme. The shares were bought at prices ranging from 1,251.00 GBp to 1,262.00 GBp and will be cancelled, reflecting the company’s strategy to manage its capital structure and enhance shareholder value.
The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has executed a share buyback program, purchasing 40,000 of its own ordinary shares at a volume-weighted average price of 1,260.46 GBp per share. This move is part of a previously announced buyback strategy and the purchased shares will be cancelled, potentially impacting the company’s share value and capital structure.
The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has announced the appointment of Peter Clarke as Chair designate, effective from July 1, 2025, pending regulatory approval. Clarke brings extensive experience from his roles in financial services and insurance, which is expected to support Hiscox’s ambitious expansion plans and strengthen its position in the insurance market. Hiscox’s CEO, Aki Hussain, expressed confidence in Clarke’s ability to contribute to the company’s growth, while also acknowledging the contributions of outgoing Interim Chair Colin Keogh.
The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd announced a correction to the payment date for its final dividend, now set for 9 June 2025, while maintaining all other details unchanged. The company is offering a scrip dividend alternative, with the Scrip Reference Share Price calculated at 1,237p based on recent market data, impacting shareholders who opted for this alternative.
The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has announced the Scrip Reference Share Price for its scrip dividend alternative, set at 1,237p. This price is determined based on the average closing market quotations from the London Stock Exchange over a specified period. The scrip dividend alternative allows shareholders to receive dividends in the form of additional shares rather than cash, with the Pound Sterling equivalent of the dividend being 22.23p per share. This move could impact shareholder value and influence the company’s financial strategy by offering flexibility in dividend payments.
The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has announced the purchase of 29,000 of its own ordinary shares as part of its share buyback programme, which was initially announced in February 2025. The shares were bought at a volume-weighted average price of 1,257.17 GBp and will be cancelled, reflecting the company’s strategy to manage its capital structure and return value to shareholders.
The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has announced the purchase and cancellation of 40,000 of its own ordinary shares as part of its share buyback program, executed through Peel Hunt LLP. This move is part of a strategic effort to manage the company’s capital structure and potentially enhance shareholder value, reflecting confidence in its financial position and future prospects.
The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has executed a share buyback transaction as part of its ongoing Buyback Programme, purchasing 36,382 ordinary shares at an average price of 1,192.39 GBp per share. This move is part of the company’s strategy to manage its capital structure and potentially enhance shareholder value by reducing the number of shares outstanding.
The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd hosted a Capital Markets Day, highlighting its strategy to deliver sustainable returns through its diversified business model and technical capabilities. The company outlined plans for its Retail business to capture opportunities in a $317 billion market, aiming for double-digit premium growth by 2028. Hiscox also announced initiatives to enhance growth and efficiency, targeting a $200 million annualized P&L benefit by 2028, and introduced new capital efficiency measures to maximize shareholder returns. The company is setting new guidance for enhanced shareholder returns, including a mid-teens operating return on tangible equity and a 20% increase in the final dividend per share for 2025.
The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has announced the purchase of 55,000 of its own ordinary shares as part of its share buyback program. The shares were bought at prices ranging from 1,193.00 GBp to 1,203.00 GBp, with a volume-weighted average price of 1,198.02 GBp. This move is part of Hiscox’s strategy to enhance shareholder value by reducing the number of outstanding shares, which may positively impact the company’s earnings per share and market perception.
The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has executed a share buyback program, purchasing 45,000 of its own ordinary shares at a volume-weighted average price of 1,196.24 GBp per share. The shares were bought through Peel Hunt LLP and will be canceled, reflecting the company’s strategic decision to manage its capital structure and potentially enhance shareholder value.
The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has announced the purchase of 40,000 of its own ordinary shares as part of its ongoing share buyback program. The shares were acquired at prices ranging from 1,174.00 GBp to 1,192.00 GBp, with a volume-weighted average price of 1,182.82 GBp. This move is part of the company’s strategy to manage its capital structure and return value to shareholders, potentially impacting its stock market performance and investor relations.
The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd announced that all resolutions proposed at its Annual General Meeting on May 15, 2025, were approved by the required majority. This includes key resolutions such as the approval of the final dividend for 2024, the 2025 Scrip Dividend Scheme, and the reappointment of several directors and auditors. The successful passing of these resolutions reflects strong shareholder support and positions the company for continued stability and growth in its operations.
The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has appointed Jane Guyett as the new Senior Independent Director, effective immediately. Jane, who joined the Board in September 2024, will replace Lynn Pike following her departure after completing a nine-year term. This leadership change is part of Hiscox’s ongoing efforts to maintain strong governance and strategic direction.
The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has announced the purchase of 15,000 of its own ordinary shares as part of its ongoing share buyback programme. The shares were acquired at a volume-weighted average price of 1,154.31 GBp and will subsequently be cancelled. This move is part of Hiscox’s strategy to manage its capital structure and return value to shareholders, potentially impacting the company’s stock value and market perception.
The most recent analyst rating on (GB:HSX) stock is a Hold with a £12.40 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has announced the purchase of 40,000 of its own ordinary shares as part of a share buyback program initiated earlier in the year. The shares were bought at varying prices, with a volume-weighted average price of 1,145.27 GBp. This move is part of Hiscox’s strategy to manage its capital structure and return value to shareholders, potentially impacting its market positioning by reducing the number of shares outstanding.
The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has announced the current estimates for its Syndicate 33 and Syndicate 6104 for the 2023 and 2024 accounts. The estimates show slight adjustments in expected returns as a percentage of capacity, with Syndicate 33’s 2023 estimates ranging from 11.3% to 21.3% and Syndicate 6104’s 2023 estimates from 29.7% to 39.7%. These updates reflect Hiscox’s ongoing strategy to manage its diverse insurance portfolio and maintain profitable growth, impacting stakeholders by potentially altering expected returns.
The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has announced the purchase of 40,000 of its own ordinary shares as part of its ongoing share buyback programme. The transaction, executed through Peel Hunt LLP, involved shares purchased at prices ranging from 1,147.00 GBp to 1,159.00 GBp, with a volume-weighted average price of 1,151.49 GBp. The acquired shares will be cancelled, which is expected to enhance shareholder value by reducing the number of shares outstanding, potentially increasing earnings per share and reflecting confidence in the company’s financial health.
The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
The Capital Group Companies, Inc., based in Los Angeles, has adjusted its voting rights in Hiscox Ltd, reducing its stake from 5.0658% to 4.959098%. This change in holdings reflects a minor adjustment in the investment strategy of Capital Group, which manages assets for various investment entities and clients. The adjustment in voting rights may have implications for Hiscox’s shareholder dynamics and influence within the company.
The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.3000 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd announced the purchase of 40,000 of its own ordinary shares as part of its ongoing share buyback program. The shares were bought at prices ranging from 1,137.00 to 1,149.00 pence and will be cancelled, potentially enhancing shareholder value by reducing the number of shares in circulation.
Hiscox Ltd has announced the repurchase of 40,000 of its own ordinary shares as part of its ongoing share buyback programme, initially announced in February 2025. The shares were purchased at a volume-weighted average price of 1,155.39 pence per share and will be cancelled, reflecting the company’s strategy to enhance shareholder value and optimize its capital structure.
Hiscox Ltd has announced the purchase of 40,000 of its own ordinary shares as part of its ongoing share buyback program. The shares were bought at prices ranging from 1,138.00 GBp to 1,150.00 GBp, with a volume-weighted average price of 1,142.88 GBp. This move is part of Hiscox’s strategy to enhance shareholder value and optimize its capital structure, potentially impacting its stock market performance and investor confidence.
Hiscox Ltd has announced the purchase of 40,000 of its own ordinary shares as part of its ongoing share buyback program. The shares were acquired at prices ranging from 1,138.00 GBp to 1,150.00 GBp, with a volume-weighted average price of 1,142.88 GBp. This move is part of Hiscox’s strategy to manage its capital efficiently and may impact shareholder value positively by reducing the number of shares in circulation.
Hiscox Ltd has executed a share buyback program, purchasing 44,143 ordinary shares at prices ranging from 1,136.00 GBp to 1,153.00 GBp, with a volume-weighted average price of 1,147.41 GBp. The repurchased shares will be canceled, which is part of the company’s strategy to manage its capital structure and potentially enhance shareholder value.
Hiscox Ltd has announced the purchase of 70,000 of its own ordinary shares as part of its share buyback program. The shares were acquired at a volume-weighted average price of 1,117.44 GBp and will be cancelled, which may impact the company’s share capital structure and potentially enhance shareholder value.
Hiscox Ltd has executed a share buyback program, purchasing 100,000 of its own ordinary shares at prices ranging from 1,085.00 GBp to 1,109.00 GBp, with an average price of 1,099.64 GBp per share. This move is part of a previously announced buyback initiative and reflects the company’s strategy to manage its capital structure effectively, potentially signaling confidence in its financial health and future prospects.
Hiscox Ltd has announced its total voting rights as of April 30, 2025, with an issued ordinary share capital of 345,677,555 shares, out of which 7,523,190 are held in Treasury and do not carry voting rights. This results in a total of 338,154,365 voting rights for shareholders, which is crucial for determining their notification requirements under the Disclosure and Transparency Rules.
Hiscox Ltd reported a 2.4% increase in group insurance contract written premiums for the first quarter of 2025, driven by growth in its Retail and London Market segments. The company is experiencing strong momentum in Europe and the US, with new commercial deals and partnerships contributing to its growth. Despite some rate reductions in certain areas, Hiscox maintains a disciplined approach to underwriting, and its investment result for the period was $114.1 million. The company’s strategic initiatives and market positioning are expected to continue supporting its growth trajectory.
Hiscox Ltd has executed a share buyback program, purchasing 100,000 of its own ordinary shares at a volume-weighted average price of 1,098.07 GBp per share. This move is part of their strategic financial management to optimize capital structure and potentially enhance shareholder value by reducing the number of shares outstanding.
Hiscox Ltd has executed a share buyback program, purchasing 100,000 ordinary shares at an average price of 1,098.07 GBp per share. This move is part of a strategic initiative to manage the company’s capital structure and could potentially enhance shareholder value by reducing the number of shares outstanding.
Hiscox Ltd announced the purchase of 90,000 of its own ordinary shares as part of its share buyback program. The shares were bought at a volume-weighted average price of 1,070.12 GBp and will be canceled, reflecting the company’s strategy to manage its capital structure and potentially enhance shareholder value.
Hiscox Ltd has executed a share buyback transaction, purchasing 80,000 of its ordinary shares at prices ranging from 1,099.00 GBp to 1,111.00 GBp, with a volume-weighted average price of 1,102.68 GBp. This move is part of its previously announced share buyback programme and is likely aimed at optimizing the company’s capital structure, potentially enhancing shareholder value by reducing the number of shares outstanding.
Hiscox Ltd announced the purchase of 25,000 ordinary shares as part of its ongoing share buyback programme. The shares were acquired at a volume-weighted average price of 1,147.51 GBp and will be cancelled, reflecting the company’s strategy to enhance shareholder value and optimize its capital structure.
Hiscox Ltd has executed a share buyback program, purchasing 40,000 ordinary shares at an average price of 1,179.56 GBp per share. This move is part of a broader strategy to enhance shareholder value by reducing the number of shares in circulation, potentially increasing earnings per share and signaling confidence in the company’s financial health.
Hiscox Ltd has executed a share buyback program, purchasing 27,795 of its own ordinary shares through Peel Hunt LLP. The shares, bought at prices ranging from 1,163.00 GBp to 1,175.00 GBp, will be cancelled, potentially impacting the company’s share value and market perception positively by reducing the number of shares outstanding.
Hiscox Ltd has executed a share buyback program, purchasing 27,795 of its own ordinary shares at prices ranging from 1,163.00 GBp to 1,175.00 GBp, with a volume-weighted average price of 1,169.67 GBp. This move is part of the company’s strategy to manage its capital structure and potentially enhance shareholder value by reducing the number of shares outstanding.
Hiscox Ltd has announced a change in its major holdings, with T. Rowe Price Associates, Inc. reducing its voting rights in the company from 5.093256% to 4.998080%. This adjustment in holdings could impact Hiscox’s shareholder dynamics and influence its strategic decisions, reflecting a shift in investment strategy by a significant stakeholder.